← Back to Bills
HR 9194118th CongressFailed / ExpiredHouse

Nucleic Acid Standards for Biosecurity Act

Policy Area: Science, Technology, Communications
View on Congress.gov
Origin Chamber
House
Last Updated
May 27, 2025
Latest Action Date
Sep 11, 2024

Latest Action

Ordered to be Reported by Voice Vote.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Nucleic Acid Standards for Biosecurity Act (H.R. 9194) was a legislative proposal introduced in the 118th Congress aimed at establishing standards related to nucleic acids for biosecurity purposes. The bill was considered in the House of Representatives and was ordered to be reported by voice vote on September 11, 2024. However, the bill ultimately failed or expired without becoming law. Specific details on the bill's provisions, including the full text and official summary, are not available in the provided data.

Bottom Line

H.R. 9194 sought to address biosecurity through nucleic acid standards but did not advance into law during the 118th Congress, with limited publicly available information on its specific content.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focused on establishing standards related to nucleic acids in the context of biosecurity.
  • It was introduced and considered in the House of Representatives during the 118th Congress.
  • The latest recorded action was that it was ordered to be reported by voice vote on September 11, 2024.
  • The bill ultimately failed or expired without enactment.
  • No official summary or full text is available from the provided source.
Who Benefits?

['Government agencies involved in biosecurity and public health', 'Scientific and research communities working with nucleic acids', 'Industries related to biotechnology and biosecurity']

Potential Concerns

['Lack of available full text and official summary limits understanding of implementation requirements and scope.', 'Potential costs and resource needs for agencies to develop and enforce nucleic acid standards are unknown.', 'Oversight mechanisms and authority delegation are unclear due to missing detailed provisions.', 'Without detailed provisions, the balance between biosecurity and scientific research freedoms cannot be assessed.']

Political Context

The bill was introduced during the 118th Congress and considered in the House of Representatives. It was ordered to be reported by voice vote, indicating some level of support or consensus at that stage. However, the bill did not progress to enactment and is recorded as failed or expired. The policy area is categorized under Science, Technology, and Communications, reflecting its focus on biosecurity standards related to nucleic acids.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could influence regulatory frameworks for biotechnology and biosecurity, potentially affecting research and commercial activities involving nucleic acids.', 'Establishing standards may lead to increased compliance costs for laboratories and companies working with nucleic acids.', 'Enhanced biosecurity measures could impact public health preparedness and response capabilities.']

GovScope Watchdog Notes

The absence of an official summary and full bill text in the source data presents a significant transparency challenge, limiting public and stakeholder understanding of the bill's specific provisions and implications. The bill's failure to advance further in the legislative process may reflect unresolved issues or lack of consensus. Future transparency efforts should ensure complete documentation is available to facilitate informed analysis and oversight.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready